The Painful Pivot: Navigating 2026's Hard Tech and Energy ReshuffleGlobal Report·1 day ago, 10:14 AMLITM0.00%CUPR+7.48%
From Solana Dreams to Sleep Apnea: The 2026 Scramble for SurvivalGlobal Report·Aug 25 at 10:12 AMDFDV-3.45%BGIN+3.87%
TRAW: Net loss increased, cash is insufficient for 12 months, and Nasdaq delisting risk remains highQuartr·Aug 14 at 08:46 PMTRAW+1.49%
Traws Pharma Reports Q2 2026 Financial Results and Provides Business HighlightsUnusual Whales·Aug 14 at 08:31 PMTRAW+1.49%
Traws Pharma risks Nasdaq delisting after shares trade below $1 for 30 daysPUBT·Jul 31 at 08:17 PMTRAW+1.49%
Traws Pharma launches at-the-market offering of up to $5.58 million in sharesPUBT·Jul 10 at 08:04 PMTRAW+1.49%
Traws Pharma targets 3Q 2026 MHRA resubmission to advance TXM Phase 2a influenza challenge studyPUBT·Jun 22 at 11:02 AMTRAW+1.49%
This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursdaybenzinga_article·Jun 18 at 12:10 PMINTU-3.37%CURB+0.20%
